EyeGate’s Ocular Bandage Gel eye drop meets endpoint

EyeGate Pharmaceuticals’ Ocular Bandage Gel eye drop improved corneal re-epithelialization better than a bandage contact lens in a pivotal PRK study, thus achieving the study’s primary endpoint, according to a press release.
A total of 80.2% of patients who received the eye drop after PRK experienced complete corneal defect closure in 3 days compared with 67% of patients who received the standard-of-care bandage contact lens, a statistically significant difference favoring the eye drop (P = .0203). The study included 234 subjects, and primary endpoint outcomes were determined in

Full Story →